← Open Payments lookup

JESSICA HAGAN: Open Payments

NPI 1265039366 · RAYVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$498 in 9 payments from 8 companies in 2025. Trend: 2023 $453 · 2024 $198 · 2025 $498

Food & beverage: $498
CompanyPaymentsAmount
Astellas Pharma US Inc1$120
Novo Nordisk Inc1$103
ABBVIE INC.1$96
Boston Scientific Corporation1$92
Amgen Inc.2$31
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$25
Bayer Healthcare Pharmaceuticals Inc.1$17
Merck Sharp & Dohme LLC1$15

Products named: Veozah, Ozempic, VRAYLAR, Intracept, OTEZLA, CAPLYTA, Kerendia, M-M-R II.

Industry payments across LA — which companies pay providers there.